#1 Clinical Trials Search in Europe

Cipepofol

Cipepofol, also known as HSK3486, is an innovative drug currently being studied in clinical trials for its potential use in general anesthesia. These trials aim to evaluate its effectiveness and safety in both adult and pediatric patients undergoing elective surgery. The research focuses on optimizing dosage, understanding its effects, and comparing it to existing anesthesia medications.

Table of Contents

What is Cipepofol?

Cipepofol is a new medication being studied for use in general anesthesia for children undergoing planned (elective) surgeries[1]. General anesthesia is a state of controlled unconsciousness that prevents a patient from feeling pain during surgery. It’s important to note that Cipepofol is still in the research phase and is not yet approved for regular use.

Purpose of the Study

Researchers are conducting a Phase III clinical trial to evaluate how well Cipepofol works and how safe it is for children[1]. A Phase III trial is typically one of the final stages before a drug can be approved for widespread use. This study is:

  • Multicenter: It’s being conducted at multiple hospitals or clinics
  • Open: Both the doctors and patients know which treatment is being used
  • Controlled: Cipepofol is being compared to another anesthetic drug

How Cipepofol is Used

In this study, Cipepofol is given as an injection in two stages[1]:

  1. Induction: A dose of 0.6±0.2 mg/kg is given to start the anesthesia. This means the dose can range from 0.4 to 0.8 mg for every kilogram of the child’s weight.
  2. Maintenance: A continuous dose of 0.8 mg/kg/h is given to keep the child asleep during surgery. This means for every kilogram of the child’s weight, 0.8 mg of Cipepofol is given each hour.

Comparison with Propofol

The study compares Cipepofol to another anesthetic drug called Propofol[1]. Propofol is a widely used anesthetic in both adults and children. In this study, Propofol is given at different doses:

  • Induction: 3.0 mg/kg
  • Maintenance: 5.0 mg/kg/h
Comparing these two drugs helps researchers understand if Cipepofol is as effective and safe as the currently used Propofol.

Measuring Success

The main goal of this study is to measure the success rate of anesthesia with Cipepofol[1]. This includes how well it works for:

  • Anesthesia induction: How effectively it puts the child to sleep at the start of surgery
  • Anesthesia maintenance: How well it keeps the child asleep during the entire surgery
The researchers will check this success rate 24 hours after the end of surgery. This allows them to assess not just how well the anesthesia worked during the operation, but also any immediate after-effects.

Importance for Patients

This study is important for young patients and their families because it may lead to a new option for anesthesia in children’s surgeries[1]. If Cipepofol proves to be safe and effective, it could provide doctors with another tool to help keep children comfortable and safe during operations. However, it’s crucial to remember that more research is needed before Cipepofol can be widely used, and the results of this study will help determine its future in pediatric anesthesia.

Aspect Details
Drug Name Cipepofol (HSK3486)
Purpose General anesthesia during elective surgery
Study Types Multi-center, randomized, open-label clinical studies
Patient Groups Adults and pediatric patients
Administration Method Target-controlled infusion (TCI)
Key Objectives Optimize TCI model, evaluate efficacy and safety, compare with existing anesthetics
Primary Outcomes Success rate of anesthesia, optimization of TCI model parameters
Comparison Drug Propofol (in pediatric study)

FAQ

  • What is Cipepofol? Cipepofol, also known as HSK3486, is a new drug being tested for use in general anesthesia during surgeries. It's currently in clinical trials to determine its effectiveness and safety.
  • How is Cipepofol administered? In the trials, Cipepofol is administered through target-controlled infusion, which means the drug is given intravenously at specific concentrations determined by the study protocol.
  • What are the main objectives of the Cipepofol clinical trials? The main objectives include verifying and optimizing the accuracy of the target-controlled infusion model, evaluating its efficacy and safety in both adult and pediatric patients, and comparing it to existing anesthesia medications like propofol.
  • Are there different dosages being tested? Yes, the trials are testing different dosages. For example, in one study, they're comparing a low-concentration group (0.9 μg/ml) with a high-concentration group (1.2 μg/ml). In another study with children, they're using 0.6±0.2 mg/kg for induction and 0.8 mg/kg/h for maintenance.
  • How is the success of Cipepofol being measured? The success of Cipepofol is being measured through various factors, including the success rate of anesthesia induction and maintenance, and by studying its effects on consciousness. Researchers are also looking at specific parameters like the effect-site concentrations at the time of loss and recovery of consciousness.

Ongoing Clinical Trials on Cipepofol

  • Study on the Safety and Effectiveness of Cipepofol Compared to Propofol for General Anesthesia in Adults Undergoing Elective Surgery

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Poland Spain

Glossary

  • Cipepofol: A new drug being tested for use in general anesthesia during surgeries, also known as HSK3486.
  • Target-controlled infusion (TCI): A method of administering drugs intravenously at specific, controlled concentrations.
  • General anesthesia: A state of controlled unconsciousness induced for surgical procedures.
  • Elective surgery: A planned, non-emergency surgical procedure.
  • Plasma target-controlled concentration: The desired concentration of a drug in the blood plasma, maintained through controlled infusion.
  • Effect-site equilibrium rate constant (Ke0): A measure of how quickly the drug concentration at the site of action equilibrates with the plasma concentration.
  • Loss of consciousness (LoC): The point at which a patient becomes unconscious due to anesthesia.
  • Recovery of consciousness (RoC): The point at which a patient regains consciousness after anesthesia.
  • Propofol: An existing anesthesia medication used as a comparison in some Cipepofol trials.
  • Induction: The initial phase of anesthesia where the patient is brought to a state of unconsciousness.
  • Maintenance: The phase of anesthesia where the patient is kept unconscious during the surgical procedure.

References

  1. https://clinicaltrials.gov/study/NCT06391931